Product Overview
- TRI‑WELL Brightening Cream is a lab‑backed topical for hyperpigmentation and melasma, developed by Sanjing (triwell).
- It targets pigmentation via a multi‑stage approach (oxidative stress, melanocyte activation, melanin synthesis, pigment transfer) and is supported by 100,000+ clinical case studies from Korean dermatologists.
- Positioned for brands seeking economically scalable, clinically verifiable brightening solutions for stubborn sun spots, post‑inflammatory pigmentation and melasma.
Product Features
- 4‑pathway melanin control: antioxidant protection, tyrosinase inhibition, blocking melanosome transfer, and suppressing inflammatory pigment signals.
- Key actives include Alpha‑Arbutin (1.8%), Tranexamic Acid (3%), Glutathione, White Truffle extract, Gentinase™ (gentian root) and Niacinamide (5%).
- Barrier‑repair complex (squalane + Centella) and a bioactive mushroom complex (matsutake, snow fungus) for hydration and DNA/photo‑damage support.
- Clean formulation: fragrance‑free, non‑comedogenic, pH‑balanced and suitable for darker skin tones (Fitzpatrick IV–VI).
Product Value
- Faster, more comprehensive spot reduction than conventional Vitamin C serums (reported ~83–86% faster in clinical comparisons).
- Multi‑correction formula reduces need for multiple separate products—treats sun spots, melasma and acne scars in one cream.
- Clinically validated actives and manufacturing expertise offer brands credible, marketable claims and reduced product development risk.
Product Advantages
- Clinically supported, multi‑mechanism approach addressing all stages of melanogenesis rather than single‑target treatments.
- High‑bioavailability and efficacious ingredient choices (e.g., Alpha‑Arbutin with deep penetration; Gentinase™ showing superior melanin inhibition vs. kojic acid).
- Formulation balances efficacy with skin tolerance and relapse prevention (reported lower rebound pigmentation rates).
- Backed by triwell’s manufacturing experience, quality control, R&D capability and scalable production infrastructure.
Application Scenarios
- Private‑label and OEM skincare lines seeking a proven brightening/anti‑pigmentation product.
- Clinical and post‑procedure care (derm clinics, aesthetic centers) for safer pigmentation management.
- Consumer lines addressing sun damage, age spots, melasma and acne scarring.
- Integrated formulations (creams, masks, targeted spot treatments) and global markets including darker phototypes.